← Open Payments lookup

RYAN SANTIN: Open Payments

NPI 1649698523 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,270 in 77 payments from 17 companies in 2025. Trend: 2023 $115 · 2024 $651 · 2025 $1,270

Food & beverage: $1,158Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.22$396
E.R. Squibb & Sons, L.L.C.16$153
Neurocrine BioSciences, Inc.7$113
Alkermes, Inc.4$111
VERTEX PHARMACEUTICALS INCORPORATED4$79
Janssen Pharmaceuticals, Inc4$73
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$63
Supernus Pharmaceuticals, Inc.3$54
Otsuka America Pharmaceutical, Inc.3$49
Lundbeck LLC2$36

Products named: UZEDY, AUSTEDO XR, INGREZZA, COBENFY, REXULTI, ARISTADA, CAPLYTA, Qelbree.

Industry payments across NE — which companies pay providers there.